NEVVI Medicare utilization intelligence

← back

HUSLIG, RICHARDM.D. NPI 1346215746 Clinician

Hematology-Oncology · LUTHERVILLE, MD

Specialty Hematology-Oncology — from billed Medicare claims
Trained UNIVERSITY OF MIAMI, LM MILLER SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 41 years since medical school (class of 1985, self-reported to CMS)
Location LUTHERVILLE, MD · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 46 codes billed · 337,138 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
LUTHERVILLE HEMATOLOGY AND ONCOLOGY SERVICES
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2015-03

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J0897 Injection, denosumab, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J3380 Injection, vedolizumab, intravenous, 1 mg
J9267 Injection, paclitaxel, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J1602 Injection, golimumab, 1 mg, for intravenous use
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1745 Injection, infliximab, excludes biosimilar, 10 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J1750 Injection, iron dextran, 50 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J2405 Injection, ondansetron hydrochloride, per 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
96372 Injection of drug or substance under skin or into muscle
96375 Injection of additional new drug or substance into vein
80053 Blood test, comprehensive group of blood chemicals
96413 Administration of chemotherapy into vein, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
J3489 Injection, zoledronic acid, 1 mg
96361 Infusion into a vein for hydration, each additional hour
96374 Injection of drug or substance into vein
J3480 Injection, potassium chloride, per 2 meq
J9045 Injection, carboplatin, 50 mg
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
J1200 Injection, diphenhydramine hcl, up to 50 mg
96415 Administration of chemotherapy into vein, each additional hour
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J3490 Unclassified drugs
96417 Administration of additional new drug or substance into vein, 1 hour or less
96360 Infusion into a vein for hydration, 31-60 minutes
96523 Irrigation of implanted venous access drug delivery device
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96409 Administration of chemotherapy into vein using push technique
96411 Administration of additional new drug or substance into vein using push technique
J2997 Injection, alteplase recombinant, 1 mg
99195 Drawing of blood for a medical problem
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
36593 Declotting of central venous tube
80048 Blood test, basic group of blood chemicals (calcium, total)
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.